- 1361–72. doi:10.1001/archgenpsychiatry.2009.104. PMID 19996041. Möller HJ,
Bandelow B,
Bauer M,
Hampel H,
Herpertz SC,
Soyka M, et al. (26
August 2014). "DSM-5...
- guidetopharmacology.org.
Retrieved 18 May 2023. Möller HJ, Müller WE,
Bandelow B (2001).
Neuroleptika –
Pharmakologische Grundlagen,
klinisches Wissen...
- List of
diagnostic classification and
rating scales used in
psychiatry Bandelow B. ****essing the
efficacy of
treatments for
panic disorder and agoraphobia...
- 1339–1349. doi:10.1038/s41380-021-01386-6. PMC 9095464. PMID 34819636.
Bandelow B, Sher L,
Bunevicius R,
Hollander E,
Kasper S,
Zohar J, et al. (June 2012)...
-
Archived (PDF) from the
original on 22
April 2017.
Retrieved 27
October 2012.
Bandelow B,
Zohar J,
Hollander E,
Kasper S, Möller HJ (October 2002). "World Federation...
- (5): 459–525. doi:10.1177/0269881115581093. PMID 25969470. S2CID 8142581.
Bandelow B,
Zohar J,
Hollander E,
Kasper S, Möller HJ (October 2002). "World Federation...
-
inhibitors (SSRIs)". nhs.uk. 15
February 2021.
Retrieved 15
January 2024.
Bandelow, Borwin; Michaelis, Sophie; Wedekind, Dirk (June 2017). "Treatment of anxiety...
-
Neurological Diseases. 1 (Suppl 1): S34–43. PMID 16400293.
Allgulander C,
Bandelow B,
Hollander E,
Montgomery SA, Nutt DJ,
Okasha A, et al. (August 2003)...
- 1016/j.pnpbp.2010.10.019. PMC 3646325. PMID 21044654. Allgulander, C.;
Bandelow, B.; Hollander, E.; Montgomery, SA.; Nutt, DJ.; Okasha, A.; Pollack, MH...
- 1357–1366. doi:10.1016/S0140-6736(17)32802-7. PMC 5889788. PMID 29477251.
Bandelow B,
Reitt M, Röver C, et al. (July 2015). "Efficacy of
treatments for anxiety...
